Opportunities and Challenges with Information Dissemination Through Social Media: FDA and Privacy-related Considerations

Event Details


June 1, 2011

Add To Calendar



AGG’s Food and Drug and Privacy Practice Teams invite you to participate a 90-minute complimentary webinar “Opportunities and Challenges with Information Dissemination Through Social Media: FDA and Privacy-related Considerations.” AGG partners Robert R. Belair, Practice Leader of the Firm’s Privacy Practice Team and Co-Chair of the Government Affairs and Public Policy Team and Alan G. Minsk, Practice Leader of the Food and Drug Practice Team will review some of the complex privacy and regulatory issues to consider.

Recently, the Food and Drug Administration announced that it has delayed the release of its long-awaited written guidance on product promotion through social media. A variety of challenging legal and public policy issues arise from using health information obtained from social network sites and other online sites depending upon the nature of the information, notice and consent by consumers, and the use to which the information is put, including in clinical trials and for marketing. As a result, companies must decide for themselves whether (and if so how) to use new mediums to disseminate information about their products, whether in the pre- or post-approval phases.

In this 90-minute webinar, our speakers will offer recommendations on how to maximize the opportunities while managing the challenges. They will discuss the implications of using personally identifiable health information obtained from social media sites and the issues arising from using health information obtained from disease awareness and other web venues. Mr. Belair, who is based in the Firm’s Washington DC office, will cover proposals in Washington that could profoundly change health privacy law, including the definition of personally identifiable information; the meaning of privacy harm; the regulatory architecture for privacy; and the new “privacy-by-design” principles that are changing consumer rights. Mr. Minsk will focus on the FDA-regulated considerations and recommendations to minimize risk. There will be a question and answer session following the presentation.


  • If you have any questions please contact Tracey Chapman, Event Coordinator at tracey.chapman@agg.com.
  • State Bar of Georiga CLE credit has been applied for.